Trial Outcomes & Findings for Model 20105 Lead Study (NCT NCT02301429)

NCT ID: NCT02301429

Last Updated: 2016-10-26

Results Overview

All Implant procedure and lead related adverse events will be collected during the first month post implant and analyzed.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

16 participants

Primary outcome timeframe

1 month

Results posted on

2016-10-26

Participant Flow

Participant milestones

Participant milestones
Measure
Model 20105
Receiving the model 20105 Lead Model 20105: implant and follow-up of study device
Overall Study
STARTED
16
Overall Study
COMPLETED
13
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Model 20105
Receiving the model 20105 Lead Model 20105: implant and follow-up of study device
Overall Study
not acceptable vascular anatomy
3

Baseline Characteristics

Model 20105 Lead Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Model 20105
n=16 Participants
Receiving the model 20105 Lead Model 20105: implant and follow-up of study device
Age, Continuous
73.2 years
STANDARD_DEVIATION 11.2 • n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
QRS duration
108.7 msec
STANDARD_DEVIATION 17.6 • n=5 Participants

PRIMARY outcome

Timeframe: 1 month

Population: all subject who underwent a Model 20105 Lead implant attempt are considered in this analysis

All Implant procedure and lead related adverse events will be collected during the first month post implant and analyzed.

Outcome measures

Outcome measures
Measure
Model 20105
n=13 Participants
Receiving the model 20105 Lead Model 20105: implant and follow-up of study device
All Implant Procedure and Lead Related Adverse Events Will be Collected During the First Month Post Implant and Analyzed.
3 Adverse Events

Adverse Events

Model 20105

Serious events: 3 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Model 20105
n=13 participants at risk
Receiving the model 20105 Lead Model 20105: implant and follow-up of study device
Injury, poisoning and procedural complications
Coronary Sinus Dissection
7.7%
1/13 • Number of events 1
Injury, poisoning and procedural complications
Iatrogenic pneumothorax
7.7%
1/13 • Number of events 1
Surgical and medical procedures
Coronary Artery Stent Insertion
7.7%
1/13 • Number of events 1

Other adverse events

Other adverse events
Measure
Model 20105
n=13 participants at risk
Receiving the model 20105 Lead Model 20105: implant and follow-up of study device
Injury, poisoning and procedural complications
Coronary Sinus Dissection
7.7%
1/13 • Number of events 1
Cardiac disorders
Atrioventricular nodal reentrant tachycardia
7.7%
1/13 • Number of events 1
Cardiac disorders
Angina Pectoris
7.7%
1/13 • Number of events 1

Additional Information

Clinical Study manager

Medtronic Regional Clinical Center

Phone: 0039(0)22 241371

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60